Shares of Masimo have moved 0.5% today, and are now trading at a price of $84.61. In contrast, the S&P 500 index saw a 0.0% change. Today's trading volume is 106,928 compared to the stock's average volume of 1,036,468.
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. Based in Irvine, United States the company has 4,000 full time employees and a market cap of $4,468,939,264.
The company is now trading -35.23% away from its average analyst target price of $130.63 per share. The 8 analysts following the stock have set target prices ranging from $110.0 to $150.0, and on average give Masimo a rating of buy.
Over the last 12 months MASI shares have declined by -41.0%, which represents a difference of -60.0% when compared to the S&P 500. The stock's 52 week high is $198.0 per share and its 52 week low is $83.03. With its net margins declining an average -12.8% over the last 6 years, Masimo declining profitability gives us reason to believe its stock price will continue to underwhelm.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2023-03-01 | 2,035,800 | 143,500 | 7 | -63.16 |
| 2022-02-16 | 1,239,200 | 229,600 | 19 | -9.52 |
| 2021-02-23 | 1,143,700 | 240,300 | 21 | 0.0 |
| 2020-02-19 | 937,837 | 196,216 | 21 | -8.7 |
| 2019-02-26 | 858,289 | 193,543 | 23 | 43.75 |
| 2018-02-28 | 790,248 | 124,789 | 16 |
